Barclays’s Pulse Biosciences PLSE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$523K Buy
34,648
+7,834
+29% +$118K ﹤0.01% 3019
2025
Q1
$431K Sell
26,814
-6,067
-18% -$97.5K ﹤0.01% 2923
2024
Q4
$573K Buy
32,881
+2,575
+8% +$44.9K ﹤0.01% 2974
2024
Q3
$530K Buy
30,306
+23,738
+361% +$415K ﹤0.01% 2959
2024
Q2
$74K Sell
6,568
-4,756
-42% -$53.6K ﹤0.01% 3519
2024
Q1
$99K Sell
11,324
-10,854
-49% -$94.9K ﹤0.01% 3649
2023
Q4
$271K Buy
22,178
+19,187
+641% +$234K ﹤0.01% 3370
2023
Q3
$11K Sell
2,991
-248
-8% -$912 ﹤0.01% 4014
2023
Q2
$23K Buy
3,239
+3,050
+1,614% +$21.7K ﹤0.01% 3942
2023
Q1
$1K Sell
189
-12
-6% -$63 ﹤0.01% 4259
2022
Q4
$1K Sell
201
-16
-7% -$80 ﹤0.01% 4330
2022
Q3
$0 Sell
217
-236
-52% ﹤0.01% 4785
2022
Q2
$1K Sell
453
-1,806
-80% -$3.99K ﹤0.01% 4636
2022
Q1
$11K Sell
2,259
-14,629
-87% -$71.2K ﹤0.01% 4469
2021
Q4
$251K Buy
16,888
+11,202
+197% +$166K ﹤0.01% 2766
2021
Q3
$123K Buy
5,686
+3,819
+205% +$82.6K ﹤0.01% 3152
2021
Q2
$31K Sell
1,867
-10,003
-84% -$166K ﹤0.01% 3591
2021
Q1
$282K Buy
11,870
+7,448
+168% +$177K ﹤0.01% 2977
2020
Q4
$105K Sell
4,422
-1,928
-30% -$45.8K ﹤0.01% 2965
2020
Q3
$75K Sell
6,350
-1,251
-16% -$14.8K ﹤0.01% 3132
2020
Q2
$79K Buy
7,601
+3,854
+103% +$40.1K ﹤0.01% 3215
2020
Q1
$27K Sell
3,747
-7,502
-67% -$54.1K ﹤0.01% 3306
2019
Q4
$151K Buy
11,249
+5,659
+101% +$76K ﹤0.01% 3304
2019
Q3
$87K Sell
5,590
-1,658
-23% -$25.8K ﹤0.01% 3470
2019
Q2
$96K Buy
7,248
+4,182
+136% +$55.4K ﹤0.01% 3611
2019
Q1
$54K Buy
3,066
+3,040
+11,692% +$53.5K ﹤0.01% 3623
2018
Q4
$0 Sell
26
-4,413
-99% ﹤0.01% 4304
2018
Q3
$63K Buy
4,439
+3,640
+456% +$51.7K ﹤0.01% 3644
2018
Q2
$12K Sell
799
-1,122
-58% -$16.9K ﹤0.01% 3853
2018
Q1
$25K Buy
1,921
+453
+31% +$5.9K ﹤0.01% 3783
2017
Q4
$35K Sell
1,468
-6,021
-80% -$144K ﹤0.01% 3494
2017
Q3
$139K Buy
7,489
+5,958
+389% +$111K ﹤0.01% 2558
2017
Q2
$53K Sell
1,531
-3,569
-70% -$124K ﹤0.01% 3003
2017
Q1
$104K Buy
+5,100
New +$104K ﹤0.01% 2814